New Axon GenePix(R) microarray scanners and Arcturus(R) Laser Capture Microdissection instrument improve research speed and precision
SUNNYVALE, CA, May 14 – MDS Analytical
Technologies, a leader in innovative solutions for drug discovery and life
sciences research, announced today the release of three new molecular
biology instruments designed to advance genomics and microgenomics
discoveries for life sciences researchers. These instruments provide
scientists flexible and open platforms to perform sensitive and specific
molecular analysis in a number of fields, including stem cell research,
cancer research, proteomics, drug discovery and many others.
Two new microarray scanners, the Axon GenePix(R) 4300A and the Axon
GenePix(R) 4400A, represent the latest in a long line of industry-leading
microarray detection and analysis systems from MDS Analytical Technologies.
These newest platforms improve the efficiency of research experiments,
reduce the cost per data point, and offer the broadest applicability in the
For researchers using laser capture microdissection (LCM), a method for
isolating cells under a microscope, the new, next-generation ArcturusXT(TM)
instrument uses the latest advances in microscope technology by employing
the Nikon Eclipse Ti-E inverted research microscope as its base. This new
technology improves speed, precision and flexibility during the
microdissection process – shortening the length of time required for
experiments and expanding application potential through an increased range
of available options.
“These new products continue our tradition of innovation and
excellence, offering reliability, flexibility, and high performance
solutions for life sciences researchers,” commented Dr. Andy Boorn,
president of MDS Analytical Technologies. “The Axon GenePix 4300A and 4400A
scanners provide customers with the ability to run the most advanced
microarray applications in the industry, which keeps them at the forefront
of this technology field. The new ArcturusXT system gives us a solid
platform upon which to offer increasingly beneficial features to
researchers who use our LCM technology.”
About MDS Analytical Technologies
MDS Analytical Technologies is a newly established MDS Inc. business
unit and is a world-class organization comprised of two main lines of
business. The Sciex product portfolio offers proven market leadership in
mass spectrometry through its joint ventures with two of the world’s
leading analytical instrumentation and life sciences companies, Applied
Biosystems, a business of the Applera Corporations and PerkinElmer Inc.
Molecular Devices’ product portfolio is the gold standard in
high-performance bioanalytical measurement systems that accelerate and
improve drug discovery and other life sciences research. Find out more at
http://www.moleculardevices.com or http://www.mdssciex.com.
About MDS Inc.
MDS Inc. (TSX: MDS; NYSE: MDZ) is a global life sciences company that
provides market-leading products and services that our customers need for
the development of drugs and diagnosis and treatment of disease. We are a
leading global provider of pharmaceutical contract research, medical
isotopes for molecular imaging, radiotherapeutics, and analytical
instruments. MDS, Inc. has more than 5,500 highly skilled people in 29
countries. Find out more at http://www.mdsinc.com or by calling 1-888-MDS-7222, 24
hours a day.